Back
Annovis Bio Vs. Akero Therapeutics Industry Stock Comparison
Sell
25
ANVS
Annovis Bio
Last Price:
8.50
Seasonality Move:
30.22%
Buy
82
AKRO
Akero Therapeutics
Last Price:
35.32
Seasonality Move:
25.06%
Sell
25
Annovis Bio (ANVS)
is a Sell
Is Annovis Bio a Buy, Sell or Hold?
- The current Annovis Bio [ANVS] share price is $8.58. The Score for ANVS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ANVS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
82
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $35.29. The Score for AKRO is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ANVS Stock Price Chart
What is Annovis Bio's stock price today?
-
The Annovis Bio share price today is $8.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $35.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 46.61 | Sell |
| Chaikin Money Flow: | 115474 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.09 - 9.49) | Sell |
| Bollinger Bands (100): | (7.02 - 10.68) | Sell |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.29 | Buy |
| Relative Strength Index (14 RSI): | 72.74 | Buy |
| Chaikin Money Flow: | 450191 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.26 - 31.9) | Buy |
| Bollinger Bands (100): | (24.11 - 29.51) | Buy |
ANVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.13 | Sell |
| 20-day SMA: | 8.92 | Sell |
| 50-day SMA: | 8.55 | Buy |
| 200-day SMA: | 9.06 | Sell |
| 8-day EMA: | 8.91 | Sell |
| 20-day EMA: | 8.91 | Sell |
| 50-day EMA: | 8.77 | Sell |
| 200-day EMA: | 9.24 | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.93 | Buy |
| 20-day SMA: | 30.6 | Buy |
| 50-day SMA: | 28.62 | Buy |
| 200-day SMA: | 24.73 | Buy |
| 8-day EMA: | 32.29 | Buy |
| 20-day EMA: | 30.83 | Buy |
| 50-day EMA: | 29.03 | Buy |
| 200-day EMA: | 26.76 | Buy |
Annovis Bio Earnings Growth & ANVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.84 per share, and a decrease next year of $0.52 per share.
Annovis Bio Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||